JAMA Health Forum Conversations cover art

All Episodes

JAMA Health Forum Conversations — 67 episodes

#
Title
1

Health Policy Research Priorities Toward Improved Rural Population Health

2

Centering Corporate Activity in the Population Health Research Agenda

3

Policy Approaches to Securing an Adequate Nursing Workforce for Years to Come

4

Aging America: Policy, Workforce, and the Future of Long-Term Care

5

Science Bearing Witness in a Post-Dobbs World

6

The Year We Lost Medicaid

7

Keeping Health Equity at the Forefront of the AI Revolution

8

Market-Based Solutions to Improve US Health Care

9

In Search of US Pharmaceutical Policy Innovation

10

The Future of Primary Care in the US

11

Changes in Policy and the Health of LGBTQ+ Populations

12

The Centrality of Women's Health to a Population Health Research Agenda

13

National Policy to Support Better Mental Health in the US

14

The Impact of Nonhealth Policies in a Time of Policy Disruption

15

The Evolution of Artificial Intelligence and Regulation

16

Improving Health and Health Care Affordability in the US with David Cutler

17

The Threat to Health Insurance Coverage in the US

18

The Potential Repercussions of Disinvestment in Health in the US

19

The US, the World Health Organization, and a New Era in Global Health

20

What's Next for JAMA Health Forum and for Health Policy?

21

Farewell Conversation With JAMA Health Forum Founding Editor in Chief John Ayanian

22

Impact of US Tobacco 21 Policies on Potential Mortality Reductions by State

23

Extreme Heat Health Consequences

24

Physician Altruism and Quality of Care

25

Health Care–Related Savings Accounts, Health Care Expenditures, and Tax Expenditures

26

Highlights From the AcademyHealth 2024 Annual Research Meeting

27

Health Care–Based Voter Registration: A New Venue to Increase Voter Participation

28

Differences in Services Provided at Public and Nonprofit Hospitals Related to the 340B Drug Discount Program

29

Measuring Medicaid Enrollment More Accurately to Guide Post–COVID-19 Pandemic Policy

30

Comparing Home Health Services in Traditional Medicare and Medicare Advantage

31

Changes in Access to Care and Preventive Services by Race and Ethnicity During the COVID-19 Pandemic

32

Opioid Prescription Duration Limits

33

Trends in Smoking Among US Adults From 2011 to 2022

34

The History, Economics, and Policy Context of Pharmacy Benefit Managers

35

Economic Burden of Untreated Mental Illness in Indiana

36

Innovative Approach to Promote Equitable Access to COVID-19 Preventive Therapy

37

How Safe Were Kids in School During Phases of the Pandemic?

38

FDA Advisory Committees for New Prescription Drugs

39

Challenges of Addressing Food and Housing Insecurity in a Medicaid Context

40

Health Care Use and Spending Among Dual-Eligible Medicare and Medicaid Beneficiaries

41

Quality of Care and Visit Volume in Federally Qualified Health Centers During COVID-19

42

Best Practice in Adjusting For Social Risk

43

Predicting Future Malpractice Claims

44

Use of Mental Health Services During the COVID-19 Pandemic

45

Factors Contributing to the Slowdown in Medicare Spending Growth

46

Increased Food Insufficiency in Households With Children

47

Helping People Enroll in Marketplace Plans

48

Receipt of Out-of-State Telemedicine Visits Among Medicare Beneficiaries During the COVID-19 Pandemic

49

Prescription Drug Cost Provisions of the Inflation Reduction Act

50

Migration and Mortality Among Patients With Kidney Failure After Hurricane Maria in Puerto Rico

51

Does Rewarding Better Patient Care Experience Punish Safety-net Hospitals?

52

A Conversation With Dr Kirsten Bibbins-Domingo, JAMA's New Editor in Chief

53

Spillover Benefits of Medicaid Expansion for Older Adults

54

Advancing COVID-19 Research in a Learning Health Care System

55

Health Care Job Loss During the Pandemic

56

COVID-19 Vaccinations for California Prison Staff

57

Medicaid Policy Associated With Increased Enrollment During the Pandemic

58

Health System Factors Related to Overuse of Health Services in Medicare

59

Unequal Burdens of Cost Sharing for Medicare Beneficiaries

60

US Share of Insulin Expenditures Going to Pharmaceutical Manufacturers and Intermediaries

61

Medicaid Use and Spending for Drugs With FDA Accelerated Approval

62

New Evidence on the Effects of the COVID-19 Pandemic on Health Insurance Coverage

63

Self-reported Access to Firearms Among Patients Receiving Care for Mental Health and Substance Use

64

COVID-19's Shock to Health Care Services

65

Time and Financial Costs for Physician Practices Participating in MIPS

66

Alternative Health Care Payment Models—The Case for A Portfolio Strategy

67

Welcome to the JAMA Health Forum Editors' Summary